Calibrate's CEO Resigns Amid Investor Pressure for Consumer Business Downsizing
Weight loss startup Calibrate is undergoing management changes as investors restructure the company, with CEO Isabelle Kenyon stepping down from day-to-day operations. Calibrate's CFO Dave Fielding is also expected to step down, and potential replacements for both roles are being interviewed. Redesign Health, the startup studio that launched Calibrate, and Madryn Asset Management, the majority funder, will play active roles in facilitating the restructuring. The company has faced challenges this year, including medication shortages and failed acquisition talks. Investors are now aiming for a "rapid down-sizing" of Calibrate's direct-to-consumer operations and providing additional funding to achieve profitability.